168 related articles for article (PubMed ID: 8566581)
21. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
22. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Trivedi TI; Gosalia NM; Ghosh N; Shah NG; Vora HH; Suthar TP
Ann Surg Oncol; 1998 Sep; 5(6):495-501. PubMed ID: 9754757
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD44 splice variants in colorectal cancer.
Wong LS; Cantrill JE; Morris AG; Fraser IA
Br J Surg; 1997 Mar; 84(3):363-7. PubMed ID: 9117309
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
27. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues.
Higashikawa K; Yokozaki H; Ue T; Taniyama K; Ishikawa T; Tarin D; Tahara E
Int J Cancer; 1996 Mar; 66(1):11-7. PubMed ID: 8608952
[TBL] [Abstract][Full Text] [Related]
29. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM
Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300
[TBL] [Abstract][Full Text] [Related]
30. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
[TBL] [Abstract][Full Text] [Related]
31. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
33. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
34. [Lgr5 and CD44 expressions in different types of intestinal polyps and colorectal cancer].
Chai N; Zhang W; Wang Y; Zhou Z; Zhang Y; Liu H; Wan J; Qin J; Wang S; Wang Y; Pei X; Wu B; Linghu E
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):972-6. PubMed ID: 23895835
[TBL] [Abstract][Full Text] [Related]
35. Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
Kawahara K; Yoshino T; Kawasaki N; Miyake K; Akagi T
J Clin Pathol; 1996 Jun; 49(6):478-81. PubMed ID: 8763262
[TBL] [Abstract][Full Text] [Related]
36. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
37. Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Kuasne H; Spencer RM; Nakagawa WT; Bezerra TS; Kupper BC; Takahashi RM; Barros Filho M; Rogatto SR; Lopes A
BMC Cancer; 2017 Nov; 17(1):754. PubMed ID: 29132333
[TBL] [Abstract][Full Text] [Related]
38. Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis.
Salahshor S; Goncalves J; Chetty R; Gallinger S; Woodgett JR
BMC Cancer; 2005 Jun; 5():66. PubMed ID: 15982419
[TBL] [Abstract][Full Text] [Related]
39. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
[TBL] [Abstract][Full Text] [Related]
40. Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Ferreira FO; Nakagawa WT; Spencer RMSB; Bezerra TS; Boggiss PE; Lopes A
Pathol Oncol Res; 2018 Jul; 24(3):533-540. PubMed ID: 28681123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]